Bio-inspired coatings for health care

LipoCoat – site under construction

*** WEBSITE UNDER CONSTRUCTION – COMING SOON ***

 

LipoCoat is a spin-off company of the University of Twente (MESA+ nanotechnology institute). Our revolutionary coating technology will make any (bio)material surface non-thrombogenic, non-fouling and resistant towards surface pollution of micro-organisms and proteins. The use of LipoCoat coatings can increase the performance, comfort and safety of your medical device or enhance research applications. In addition, we provide a service to tailor coating properties and functionality to meet your demand.

Our Partners

LipoCoat’s ecosystem consists of numerous partners that support LipoCoat to bring it to the next level and introduce the next generation of surface coatings to the market.

News

Below you find news articles about the LipoCoat developments through the years.

07-2017

600.000 euro funding for Dutch biotech coating startup

LipoCoat BV, a spin-off from the MESA+ nanotechnology institute from the University of Twente, gathered nearly 600.000 euro funding.

This milestone was reached with grants from the government, a loan from Redmedtech Ventures and recent investments from LLX2 Investments and an informal investor. LipoCoat develops coatings for the medical industry.

NANOTECH SPIN-OFF OF THE YEAR

LipoCoat BV has developed an innovative coating inspired by nature. The LipoCoatTMcoatings are biocompatible and provide unprecedented resistance towards pollution of proteins, bacteria and even human cells.  LipoCoat BV is developing numerous coating formulations with anti-fouling, lubricious, and multi-functional properties as well as novel processing techniques. The properties of LipoCoat™ coatings can be tailored to meet customer requirements. In 2016 the company won the title ’Nanotech startup of the year’ and is currently running for the Accenture Innovation Awards 2017.  By the beginning of 2017 the company had expanded to 9 employees and future growth is foreseen.

SEVERAL APPLICATIONS

As a result of the tunable properties of LipoCoatTM coatings, the coatings can be used on most (bio)materials, medical devices, diagnostic tools and on R&D devices. In the future, LipoCoat BV wants to explore opportunities in health, food and pharma. LipoCoat BV is currently co-developing with a multinational and is actively pursuing new opportunities. For the coming two years LipoCoat will carry out their research and production in the labs of the University of Twente.

FUNDING STRATEGY

With 600K in funding LipoCoat is able to finance initial product development, prepare market entry, and invest in R&D applications and customer relationships. LipoCoat has sufficient resources to last well within 2018. The goal is to attract 2 million in series A funding in 2018. A road show to Boston-USA and Silicon Valley is already planned for the Fall of 2017.

Source: University of Twente
12-2016

LipoCoat Celebrated MicroNano Start-Up of the Year 2016

The highly promising company LipoCoat, from the Eastern Netherland’s city of Enschede won the second edition of the MicroNano Start-Up of the Year contest. At the closure of the two day International MicroNano Conference in Amsterdam LipoCoat’s Director of Business Development, Raoul Oostenbrink- received the award from Ronny van ’t Oever, president of the organising MinacNed. The jury of seven experts from a number of countries characterized the winning pitch with the words “A Firm Business Case, Good Market Chances and Solving a Problem of Today”.

Source: MinacNed
Micronano start-up of the year
09-2016

LipoCoat BV officially founded

The University of Twente startup LipoCoat BV develops unique coatings for e.g. medical devices. The coatings are designed to improve performance, safety and comfort of medical devices but can also be used in, for example, R&D applications. By founding LipoCoat BV, the next steps can be taken towards market entry. Photo: Left; Prof. Pascal Jonkheijm, co-founder and R&D advisor LipoCoat BV Middle; Jasper van Weerd, founder and managing director LipoCoat BV Right; Prof. Marcel Karperien, co-founder and R&D advisor LipoCoat BV.

LipoCoat officially founded
02-2016

LipoCoat awarded NanoNextNL valorization grant

Contactlenzen die irriteren, veel gebruikers weten er alles van. Het Enschedese bedrijf LipoCoat, een spin off van de Universiteit Twente, brengt verlossing met een extreem dunne en vuilafstotende coating. Om het prototype lens met zo’n irritatievoorkomend laagje door te ontwikkelen en een dragersonderzoek voor te bereiden krijgt LipoCoat nu 93.000 euro van NanoNextNL.

Source: De Ondernemer
NanoNextNL valorization grant

Team

The LipoCoat members

Jasper van Weerd Ph.D

(Managing director)

Jasper van Weerd is Managing Director of LipoCoat BV and developed the LipoCoat technology during his PhD at the University of Twente. After his PhD, he founded LipoCoat BV to explore the full potential of the technology. Jasper’s mission is to improve performance, comfort & safety of medical devices and R&D tools by continuously stimulating new developments, new applications and innovative coating formulations to suit customer needs.

Raoul A. Oostenbrink MSc

(Director of Business Development)

Raoul Oostenbrink is Director of Business Development at LipoCoat BV. Raoul previously worked as VP of marketing & sales at CD Leycom (Teleflex) and managed business development for TNO and the NanoNextNL programme. Raoul’s has a broad international experience in the areas of Sales and Business Development. As part of LipoCoat BV, Raoul is responsible for strategic management, sales & marketing.

Alain le Loux MSc MBA

(Director of Strategy & Finance)

Alain le Loux is Director of Strategy and Finance at LipoCoat BV. After a career at PinkRoccade and Getronics, Alain was successful as CEO of Virobuster and, since 2002, is a startup & CEO coach and has coached more than 200 startups in Europe. He serves as a part-time business developer at Novel-T and partner in Cottonwood Technology Fund. Alain has a track record of making startups a success. As part of LipoCoat, Alain is responsible for LipoCoat's strategy, finance and funding roadmap.

Milou ten Hove Ph.D

(R&D and QA)

Milou ten Hove heads R&D and QA at LipoCoat BV. Milou has a technical medicine background and has worked as a researcher at the Diabetes Research Institute USA, Case Wester Reserve University USA, UMC Radboud, UMC Utrecht and University of Twente. Milou thrives at the interface between the clinic and novel biomedical applications. As part of LipoCoat, Milou oversees LipoCoat R&D and is responsible for quality assurance.

Michaela Campagna MSc

(Production and R&D)

Michaela Campagna studied at Sapienza University of Rome and graduated her Masters' degree at the University of Twente in 2016. She used the following techniques: isothermal amplification reactions (multiple displacement amplification) and PCR, gel electrophoresis, chemical functionalization on glass surfaces and fluorescence detection techniques.

Prof. Pascal Jonkheijm

(R&D advisor)

Pascal Jonkheijm is a R&D advisor of LipoCoat BV and a professor of Bioinspired Molecular Engineering at the University of Twente. Pascal's interests lie in dynamic chemical strategies to understand, to direct and to manipulate cellular processes by the use of smart biomaterials. Pascal has a keen understanding of surface chemistry, supramolecular chemistry and synthetic biology. Pascal helps to develop new chemical strategies for LipoCoat BV.

Prof. Marcel Karperien

(R&D advisor)

Marcel Karperien is a R&D advisor of LipoCoat BV and a professor of Developmental BioEngineering at the University of Twente. Marcel's work is characterized by a multidisciplinary approach, combining e.g. polymer chemistry with tissue engineering. Marcel’s work has led to the creation of Percuros BV and Hy2Care. Marcel’s expertise in biology, medical devices and biomaterials contributes to LipoCoat’s streamlined medical application development.

Charline Kuipers

(Junior R&D)

Charline Kuipers is a junior R&D employee at LipoCoat BV from the Saxion University of Applied Sciences. Charline is studying Biology and Medical Laboratory Research and is working on in vivo evaluation LipoCoat coatings on biomaterials.

Tanja Maarse

(Junior R&D)

Tanja Maarse is a junior R&D employee at LipoCoat BV from the Saxion University of Applied Sciences. Tanja is studying Biology and Medical Laboratory Research and will continue working on prototype development of new LipoCoat coatings for exotic medical devices.

Jonathan Stek

(Junior R&D)

Jonathan Stek is a junior R&D employee at LipoCoat BV from the Saxion University of Applied Sciences. Jonathan is studying Chemistry and will work on new coating formulations and processing techniques.

Eva Huiskes

(Finance)

LipoCoat’s finance department is managed by Eva Huiskes.

Michelle van Dalen

(Logistics)

LipoCoat’s logistics department is managed by Michelle van Dalen. Michelle is responsible for purchase of goods and ingredients, logistics of products and all other back-office activities. She can be reached during office hours by phone or e-mail on office (a) lipocoat.com. Michelle finished recently her business office study at ROC van Twente.

Tim Greven

(Former IBA intern)

Tim Greven was an International Business Administration intern at LipoCoat BV from the University of Twente. From 4-2016 till 6-2016, Tim performed market analysis in the medical device field.

Björn Kamphuis

(Former junior R&D)

Björn Kamphuis was a junior R&D employee at LipoCoat BV from the Saxion University of Applied Sciences (Biology and Medical Laboratory Research). From 9-2016 till 1-2017, Björn worked on prototype development of new LipoCoat coatings for exotic medical devices.

()

()

Toggle former members

Technology

In virtually all applications where biological material such as bodily fluids, living cells or tissue are brought into contact with man-made materials unwanted (side) effects are observed. These are often attributed to surface fouling of the material. The LipoCoat technology consists of a bio-inspired coating that is able to resist fouling of proteins, cells and micro-organisms. Our proprietary coating technology can be applied on a wide range of (bio)materials in a wide range of applications such as medical, R&D, food, dairy and (micro)fluidics. The LipoCoat coatings are well-hydrated, can regenerate, consist of naturally occurring molecules and is only several nanometers thick.

LipoCoat and anti-coagulation

Media

Contact

LipoCoat B.V.

Contact information

W: www.lipocoat.com

E: info@lipocoat.com

T: +31 [0] 53 – 82 00 816

F: +31 [0] 53 – 82 00 813

KvK: NL 66706858

VAT: NL 856667195 B01

Office hours

Mon-Fri: 8:30 – 17:00
(Timezone: CET / GMT+1)

Post

LipoCoat B.V.
PO Box 217
7500 AE Enschede
The Netherlands

Visiting address

CR.4061, Carré building

University of Twente

Drienerlolaan 5

7522 NB Enschede

The Netherlands

Social Media: